Document Detail


Hypoglycaemia-insulin test: discordant growth hormone and cortisol response in paediatric patients regarding recovery from hypoglycaemia with or without oral glucose solution.
MedLine Citation:
PMID:  17028439     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Hypoglycaemia-insulin test (HIT) is the 'gold standard' for the diagnosis of adrenal-pituitary-hypothalamic axis disorders. Controversy exists on the convenience of recovery from an insulin-induced hypoglycaemia since this test is not risk-free. OBJECTIVE: To ascertain whether recovery from insulin-induced hypoglycaemia with an oral glucose solution produces a different response of growth hormone (GH) and cortisol at different times of the study compared with spontaneous recovery from hypoglycaemia. PATIENTS AND METHODS: Prospective study of 100 children and adolescents with growth delay who underwent an HIT. Patients were consecutively assigned to two groups of 50. In one group recovery from hypoglycaemia occurred spontaneously and in the other recovery was achieved with an oral glucose solution (20 g of glucose) when glycaemia was under 30 mg/dl. The two groups did not differ in age, sex, pubertal status, weight, height and IGF-I levels. RESULTS: The response of GH at 30, 60, 90 and 120 min and cortisol at 10, 60, 90 and 120 min was lower and statistically significant in patients with recovery from hypoglycaemia with oral glucose solution. GH deficiency was diagnosed more frequently in patients recovered with glucose solutions (94%) compared to those with spontaneous recovery (68%). CONCLUSIONS: Oral glucose solution administration when glycaemia was under 30 mg/dl in HIT produced a lower GH and cortisol response to insulin stimulus and a greater frequency of GH deficit diagnosis.
Authors:
Diego Yeste; Rosangela Tomasini; Gabriela Dodino; Miquel Gussinyé; Neus Potau; Antonio Carrascosa
Related Documents :
19107319 - Glycaemic profile characteristics and frequency of impaired awareness of hypoglycaemia ...
2887309 - On the use of a new somatostatin analogue in the treatment of hypoglycaemia in patients...
19920979 - Tolerability, safety and adherence to treatment with insulin detemir injection in the t...
9792329 - Inhibition of luteinizing hormone secretion and expression of c-fos and corticotrophin-...
18307459 - In type 1 diabetic patients with good glycaemic control, blood glucose variability is l...
19922879 - Comparison of insulin detemir and insulin glargine in a basal-bolus regimen, with insul...
19470629 - Short-term effects of the long-acting insulin analog detemir and human insulin on plasm...
14768769 - In vivo effect of vitamin c with cobalt on oxidative stress in experimental diabetic ra...
21470009 - Adolescent bmi trajectory and risk of diabetes versus coronary disease.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article     Date:  2006-10-04
Journal Detail:
Title:  Hormone research     Volume:  67     ISSN:  0301-0163     ISO Abbreviation:  Horm. Res.     Publication Date:  2007  
Date Detail:
Created Date:  2007-02-14     Completed Date:  2007-03-29     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0366126     Medline TA:  Horm Res     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  42-5     Citation Subset:  IM    
Copyright Information:
Copyright (c) 2007 S. Karger AG, Basel.
Affiliation:
Paediatric Endocrinology, Children's Hospital Vall d'Hebron, Autonomous University of Barcelona, Barcelona, Spain. dyeste@vhebron.net
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Anthropometry
Case-Control Studies
Child
Female
Glucose / therapeutic use
Growth Disorders / blood*,  diagnosis
Human Growth Hormone / blood*,  deficiency
Humans
Hydrocortisone / blood*
Hypoglycemia / blood*,  chemically induced,  drug therapy
Hypothalamo-Hypophyseal System / physiopathology
Insulin / administration & dosage,  blood
Male
Pituitary Function Tests / methods*
Puberty / blood
Stimulation, Chemical
Chemical
Reg. No./Substance:
11061-68-0/Insulin; 12629-01-5/Human Growth Hormone; 50-23-7/Hydrocortisone; 50-99-7/Glucose

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Direct protection by a gonadotropin-releasing hormone analog from doxorubicin-induced granulosa cell...
Next Document:  Unique deletion in exon 5 of SHOX gene in a patient with idiopathic short stature.